Eli Lilly pandemic crisis patient Coronavirus Eli Lilly

Drugmaker caps insulin costs amid coronavirus pandemic

Reading now: 128
www.clickorlando.com

Eli Lilly said Tuesday that it will limit the out-of-pocket cost of insulin to $35 per month. The move comes in response to offset the financial hardships due to the coronavirus pandemic.

The co-pay cap will cover the majority of the pharmaceutical company's insulin, including the humalog injection. The program is open to the uninsured as well as commercially insured people with type 1 diabetes, but the pharmaceutical company said it is not available to Medicaid, Medicare or Medicare Part D patients.

The savings can be obtained by calling the diabetes solution center toll-free line. Insulin prices spiked nearly 100% from 2012 to 2016.

Read more on clickorlando.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA